Critical Comparison: TransMedics Group (NASDAQ:TMDX) & Gadsden Properties (OTCMKTS:GADS)

TransMedics Group (NASDAQ:TMDX) and Gadsden Properties (OTCMKTS:GADS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for TransMedics Group and Gadsden Properties, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	0	1	8	0	2.89
Gadsden Properties	0	0	0	0	N/A

TransMedics Group presently has a consensus price target of $171.44, indicating a potential upside of 19.22%.

Risk and Volatility

TransMedics Group has a beta of 1.99, indicating that its stock price is 99% more volatile than the S&P 500. Comparatively, Gadsden Properties has a beta of -4.55, indicating that its stock price is 555% less volatile than the S&P 500.

Insider and Institutional Ownership

99.7% of TransMedics Group shares are held by institutional investors. 7.0% of TransMedics Group shares are held by company insiders. Comparatively, 5.0% of Gadsden Properties shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares TransMedics Group and Gadsden Properties’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TransMedics Group	0.84%	15.98%	3.41%
Gadsden Properties	N/A	N/A	N/A

Earnings and Valuation

This table compares TransMedics Group and Gadsden Properties”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$241.62 million	19.86	-$25.03 million	($0.34)	-422.97
Gadsden Properties	N/A	N/A	N/A	N/A	N/A

Gadsden Properties has lower revenue, but higher earnings than TransMedics Group.

Summary

TransMedics Group beats Gadsden Properties on 8 of the 8 factors compared between the two stocks.

About TransMedics Group

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

About Gadsden Properties

Gadsden Properties, Inc. is a Nevada corporation that was formed on December 28, 2010. Gadsden concentrates primarily on investments in high quality income-producing assets, residential developments and other opportunistic commercial properties in secondary and tertiary markets across the United States. The Company derives value from smaller, flexible retail investments that range from $5 million to $50 million and off-market mixed-use properties ranging from $50 million to $250 million. As a result of this chosen strategy, we believe that Gadsden is developing a unique competitive advantage that generally allows the Company to invest in markets and assets that are often overlooked by larger institutional investors, such as publicly-traded REITs and other large institutional investors. As part of its strategy, Gadsden attracts specific sellers that prefer the tax deferral advantages offered through issuing operating partnership units in exchange for their properties. These real estate assets are typically operated by independent owners that are seeking to monetize their real estate holdings, and who are typically not well capitalized or well-seasoned real estate operators. These transactions create a variety of outcomes for Gadsden and the sellers typically resulting in lease-up and value-added opportunities that may not be otherwise achieved.